...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Endpoints article about Pfizer and M&A

I'll limit my comments because the thought police have clearly demonstated that they have issues with my posts! We'll see if my use of italics triggers them this time.

Thank you for the post George! You will definitely like a few of the comments in this transcript.

https://www.fool.com/earnings/call-transcripts/2020/04/28/pfizer-inc-pfe-q1-2020-earnings-call-transcript.aspx

Share
New Message
Please login to post a reply